Cristina Saura Manich, MD, PhD - First-Line Treatment of HER2-Positive Metastatic Breast Cancer: Could Investigational Approaches Improve on Current Standard of Care?

For the complete activity, including supporting material, please visit https://www.peervoice.com/GNV860. Presented by Cristina Saura Manich, MD, PhD and Aditya Bardia, MD. Learning Objectives: Evaluate the clinical data for emerging therapeutic strategies for the management of HER2+ metastatic breast cancer in the first-line setting; Discuss key learnings from clinical trials for investigative first-line treatment approaches for HER2+ metastatic breast cancer in context of different patient and disease characteristics.

Listen